We are live on ! Find out more
CERO

CERo Therapeutics
CERO

Delisted

CERO was delisted on the 30th of October, 2025.

Back to rankings

Fund managers haven’t disclosed any holdings of CERO yet.

CERO Hedge Fund Activity: Q4 2025 in Review

0 of the 8,238 institutional investors tracked by Wall St. Rank reported a position in CERo Therapeutics (CERO) for Q4 2025, worth a combined $0 — down 100% from $799K a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of CERO and 0 opened new positions — a net loss of 11 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Parallel Advisors, exiting entirely with an estimated $616K sold.

  • 0 institutional investors held CERo Therapeutics (CERO) as of Q4 2025, down from 11 in Q3 2025.
  • Funds reported $0 of CERo Therapeutics stock for Q4 2025, down 100% quarter-over-quarter.
  • 0 funds opened new CERo Therapeutics positions in Q4 2025 and 11 closed out, a net change of -11 holders.
  • The largest CERo Therapeutics seller in Q4 2025 was Parallel Advisors, an estimated $616K sold.

Based on aggregated 13F filings for Q4 2025.